Ovid Therapeutics Inc.

8-K Director or officer change Jul 8, 2026 8-K Shareholder vote results Jun 11, 2026 8-K Director or officer change Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K May 12, 2026 8-K Other events Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity Mar 18, 2026 8-K Other events Dec 18, 2025 8-K Shareholder vote results Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Director or officer change Nov 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Oct 3, 2025 8-K Other events Sep 16, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Aug 13, 2025 8-K Shareholder vote results Jul 10, 2025 8-K Other events Jun 25, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Item 5.08 May 2, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Director or officer change Mar 5, 2025 8-K Delisting notice or listing-rule failure Feb 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Nov 12, 2024 8-K Director or officer change Sep 11, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Aug 13, 2024 8-K Director or officer change Aug 2, 2024 8-K Other events Jul 1, 2024 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure Jun 28, 2024 8-K Regulation FD disclosure Jun 17, 2024 8-K Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 8, 2024 8-K Results of operations (earnings release) Mar 8, 2024